Navigation Links
ENTrigue Surgical Announces Sinus Surgery Collaboration with fiagon GmbH
Date:9/6/2012

SAN ANTONIO, Sept. 6, 2012 /PRNewswire/ -- ENTrigue Surgical, Inc. ("ENTrigue"), a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today a collaboration agreement with fiagon GmbH, a company based in Berlin, Germany, that develops and manufactures a new generation of intelligent and highly portable navigation systems for ENT, oral and maxillofacial surgery and neurosurgery.   As part of their collaboration, ENTrigue and fiagon will explore the delivery of integrated navigation and therapy solutions for ENT procedures starting with ENTrigue's Ventera® Sinus Dilation System in Europe.

Dr. Timo Kruger, fiagon CEO, commented, "The team at fiagon is excited to be working with the experienced ENT industry professionals at ENTrigue.   We are encouraged by the possibilities."

The ENTrigue Ventera® Sinus Dilation System includes a single-use balloon delivered by one of several reusable instruments utilizing ENTrigue's proprietary SerpENT® articulating technology and does not require either manual tip shaping or the use of a guide wire or cannula to deliver the balloon into various sinuses. The Ventera® Sinus Dilation System is the only balloon system that can be inserted transnasally and then articulated in-place to best access any sinus cavity.  The combination of real-time navigation with balloon dilation is expected to significantly enhance the capability of ENT surgeons to perform minimally invasive sinus surgery.  

Fred Dinger, ENTrigue CEO, added, "Integrating fiagon's  navigation to our sinus dilation platform will provide the ENT surgeon with an unparalleled level of confirmation of balloon position within the sinus anatomy.  We look forward to collaborating with fiagon to combine two game-changing platforms with the goal of brin
'/>"/>

SOURCE ENTrigue Surgical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
2. GHX Selects MicroStrategy to Offer Healthcare Suppliers Enhanced Access to Distributed Medical-Surgical Market Data
3. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
4. Millennium Surgical Corp. Named to Inc. 5000 List of Fastest Growing Private Companies for The Second Year
5. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
6. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
7. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) - Global forecast, Market Share, size, growth and industry analysis (2010-2017)
8. Regional Medical Center at Memphis Completes Rapid Six-Month Implementation of Comprehensive Perioperative and Anesthesia Solution from Surgical Information Systems
9. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
10. STAAR Surgical Reports Second Quarter 2012 Financial Results
11. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Fla. , Sept. 19, 2014  The body ... with the publication of two papers this past week.  ... – Head and Neck Surgery , finds that ... and subjective measures of sleep disordered breathing, leading the ... reduction in obstructive sleep apnea severity and improvement of ...
(Date:9/19/2014)... 2014 Intarcia Therapeutics, Inc. today ... its lead candidate ITCA 650 (continuous subcutaneous delivery of ... HbA1c levels at the 50 th Annual Meeting ... (EASD). Data from the open-label, phase 3 FREEDOM-HBL (high ... in patients with poorly controlled type 2 diabetes. The ...
(Date:9/19/2014)... 2014 Reductions in kidney failure ... in people with diabetes type 2 "Intensive ... for the kidneys." Australian researchers have discovered ... diabetes leads to persistent reductions in kidney failure many ... global study has found that, five and a half ...
Breaking Medicine Technology:New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3
... SAN DIEGO, Jan. 7 Trius Therapeutics, Inc. ... clinical trial of TR-701, an,antibacterial drug candidate intended ... including those caused by MRSA,and other drug-resistant strains. ... will test tolerability, safety and,pharmacokinetics of the oral ...
... Ill., Jan. 7 Baxter International,Inc. (NYSE: ... pre-clinical,programs to develop recombinant Factor IX proteins to ... recombinant Factor IX therapy for,treatment of acute bleeding ... Factor IX therapy for prophylaxis of bleeding in,hemophilia ...
Cached Medicine Technology:Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 3
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... over the five years to 2014. Industry operators were ... time during the period, as well as establish distribution ... is due in large part to its novelty; energy ... Nevertheless, in that time, industry operators have been able ...
(Date:9/19/2014)... MD & Salt Lake City, UT (PRWEB) September 19, ... to launch the new Activz Greens Smoothie ... Products Expo East, September 18th-20th in Baltimore, MD. ... with 8 organic super foods combined in one convenient ... Natural Products Expo East, September 18th-20th in Baltimore, MD. ...
(Date:9/19/2014)... (SALT LAKE CITY)A new study by researchers at the ... a longstanding question about the role of mitochondria in ... a new mouse model to study such illnesses. ... Ph.D., professor of biochemistry, found that when healthy, functioning ... fibers that conduct electricity away from neurons mice ...
(Date:9/19/2014)... as Johne,s disease, is caused by the bacterium ... Austria, there is a legal obligation to report ... treatment-resistant diarrhoea and wasting among affected animals. The ... farms. The animals produce less milk, exhibit fertility ... such as udder inflammation. , To date ...
(Date:9/19/2014)... 19, 2014 Lifeinsure.biz has released ... riders that can be purchased without medical examinations. ... and make a life insurance policy more advantageous. Clients ... more about extra options available for a no medical ... medical examinations required is simple to purchase, however it ...
Breaking Medicine News(10 mins):Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 2Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 3Health News:Mouse model sheds light on role of mitochondria in neurodegenerative diseases 2Health News:Mouse model sheds light on role of mitochondria in neurodegenerative diseases 3Health News:Lymphatic fluid used for first time to detect bovine paratuberculosis 2Health News:No Medical Exam Life Insurance - Lifeinsure.biz Presents 5 Important Riders! 2
... found to be the combination of dry eyes and mouth//, ... symptoms include dry, gritty or burning eyes, intermittent blurry vision, ... enlarged parotid glands. The parotids are a pair of salivary ... Other signs and symptoms may include dry skin or vaginal ...
... treatments has been accused of placing money before patients//, ... drug. <BR.,Patients suffering from cancer linked to asbestos will ... is pemetrexed disodium, after a study conducted ... ,The group analyzed the cost effectiveness of the ...
... new fat-busting laser treatment called SmartLipo. It is to be ... less invasive form of liposuction//. It removes unsightly lumps of fat ... About six cosmetic surgery clinics in London, the Midlands and the ... Food and Drug Administration (FDA) has not approved to the procedure ...
... investigators at John Hopkins Children’s Center//, patient’s safety system can ... errors into a computer database. ,Hopkins researchers ... reporting on the errors voluntarily plus steps taken to overcome ... not new, but few studies have looked at the accuracy ...
... commercial production at its Dehradun unit. // ,The ... pharmacuetical formulations unit would achieve a capacity level of 300 ... in stages., ,Plans of establishing a parenterals division at ... the company was trading at Rs 102.35, down 4.48 per ...
... have died after catching bird flu from wild swans//. ... said that they had occurred earlier this year. They also went ... avian flu that were being passed on from the wild birds. ... a village in Azerbaijan, and are believed to have caught the ...
Cached Medicine News:Health News:Voluntary Error-Reporting System Ensures Patient Safety 2Health News:Voluntary Error-Reporting System Ensures Patient Safety 3Health News:Voluntary Error-Reporting System Ensures Patient Safety 4Health News:Four Deaths Due To Bird Flu Caught From Wild Birds 2
For the quantitative in vitro determination of Apolipoprotein A-1 in human serum....
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
The BUN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of urea nitrogen in serum, plasma and urine....
The GGT method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of g-glutamyl transferase activity in serum and plasma...
Medicine Products: